Ascendis Pharma A/S

IPO

Ascendis Pharma: Patients. Science. Passion.

Public · Hellerup, Denmark · Founded 2007 · $85.7M raised

Headquarters
Hellerup
Employees
501–1000
Founded
2007
Business Model
B2B
Total Funding
$85.7M
Last Round
$60.0M Series DDec 2014
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 6 investors for this company. The full record is or through the API.

About

Ascendis Pharma is applying its TransCon technology platform to build a leading, fully integrated global biopharmaceutical company. Founded in 2007 and headquartered in Copenhagen, Denmark, the company is publicly traded on Nasdaq (ASND) following its 2015 IPO. Guided by the core values of Patients, Science, and Passion, Ascendis develops new therapies with best-in-class potential that address unmet medical needs, with a pipeline focused on endocrinology rare diseases and an expanding effort in oncology.

Summary

Ascendis Pharma A/S is a Biotech company based in Hellerup, Denmark, founded in 2007. It has raised $85.7M in total across 3 rounds, most recently a $60.0M Series D round in Dec 2014. Investors include Sofinnova Partners, OrbiMed and Gilde Healthcare.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOJan 2015
$124.2M

Sign up to see all 4 events

Funding: Series A through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ascendis Pharma A/S on Indexed.vc
<a href="https://indexed.vc/companies/ascendis-pharma-a-s"><img src="https://indexed.vc/api/badge/company/ascendis-pharma-a-s" alt="Ascendis Pharma A/S on Indexed.vc" width="260" height="76" /></a>